期刊文献+

炎症因子IL-23对黑色素瘤B16F10细胞增殖和侵袭能力的影响 被引量:1

Effects of IL-23 on proliferation and invasion of B16 melanoma cells
下载PDF
导出
摘要 目的:探讨白细胞介素-23(IL-23)对黑色素瘤B16F10细胞增殖和侵袭能力的影响。方法:体外培养小鼠黑色素瘤B16F10细胞,采用MTT法检测IL-23对B16细胞增殖能力的影响;Transwell侵袭实验检测IL-23对B16细胞侵袭能力的影响;明胶酶谱法分析IL-23处理后肿瘤细胞B16细胞分泌MMP-2和MMP-9的活性表达情况。免疫印迹杂交法检测IL-23处理组肿瘤细胞核转录因子κB P65(NF-κB P65)的表达水平。结果:与对照组相比,IL-23处理组B16F10细胞穿膜数明显增多(P<0.01);肿瘤细胞MMP-2和MMP-9的表达活性增强(P<0.01);核转录因子NF-κB P65的表达水平显著提高(P<0.01);B16细胞的增殖能力未见明显变化(P>0.05)。结论:IL-23对黑色素瘤B16F10细胞的增殖能力无影响,可通过上调MMP-2和MMP-9的活性促进肿瘤细胞侵袭,其分子机制可能与NF-κB信号通路的激活相关。 Objective: To investigate the effects of interlukin-23 (IL-23) on the proliferation and invasion of mouse B16F10 melanoma cells. Methods: Mouse B16 melanoma cells were cultured in vitro. Cells in research were treated with and without a certain-concentration IL-23 respectively. The proliferation of B16 cells was determined by MTT. And the invasion of B16 cells was detected by Transwell experiment. The expression activities of MMP-2 and MMP-9 were analyzed by Gelatin Zymography and NF-KB phosphorylated P65 expression was measured by Western blot. Results: The growth rate of B16 cells treated with IL-23 did not show significant change (P〉0.05) compared with the control group. Matrigel invasion assay revealed that addition of IL-23 to B16 cells significantly enhanced its invasive properties (P〈0.01), and Gelatin Zymography analysis showed that the MMP-9 activity of B16F10 cells was significantly increased by IL-23 (P〈0.01). IL-23 induced an increased NF-KB phosphorylated P65 expression in B16 cells. Conclusion: IL-23 brings no effect on proliferation of B16F10 cells but can promote invasion which is associated with the increased MMP-9 activities, and this process is correlated with NF-KB signal pathway activation.
出处 《天津医科大学学报》 2014年第1期8-10,13,共4页 Journal of Tianjin Medical University
基金 天津市自然科学基金资助项目(10JCZDJC20400)
关键词 IL-23 B16细胞 黑色素瘤 基质金属蛋白酶 侵袭 NF—KB 小鼠 IL-23 melanoma B 16 cells matrix metalloproteinase invasion NF-KB mice
  • 相关文献

参考文献10

  • 1Kortylewski M,Xin H,Kujawski M. Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment[J].{H}CANCER CELLS,2009,(02):114.
  • 2Teng M W,von Scheidt B,Duret H. Anti-IL-23 monoclonal antibody synergizes in combination with targeted therapies or IL-2 to suppress tumor growth and metastases[J].{H}CANCER RESEARCH,2011,(06):2077.
  • 3Langowski J L,Zhang X,Wu L. IL-23 promotes tumour incidence and growth[J].{H}NATURE,2006,(7101):461.
  • 4Li J,Zhang L,Zhang J. Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor[J].{H}CARCINOGENESIS,2013,(03):658.
  • 5Li J,Lau G,Chen L. Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression[J].PLoS One,2012,(09):e46264.
  • 6房东亮,马跃美,赵秀兰,孙涛,刘艳荣,王倩,田原.慢性炎症对小鼠黑色素瘤血管生成的影响[J].天津医药,2013,41(3):230-233. 被引量:6
  • 7Kessenbrock K,Plaks V,Werb Z. Matrix metalloproteinases:regulators of the tumor microenvironment[J].{H}CELL,2010,(01):52.
  • 8Li J,Lau G K,Chen L. Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression[J].PloS One,2011,(07):e21816.
  • 9Colotta F,Allavena P,Sica A. Cancer-related inflammation,the seventh hallmark of cancer:links to genetic instability[J].{H}CARCINOGENESIS,2009,(07):1073.
  • 10Grivennikov S I,Karin M. Dangerous liaisons:STAT3 and NF-κB collaboration and crosstalk in cancer[J].{H}Cytokine & Growth Factor Reviews,2010,(01):11.

二级参考文献2

共引文献5

同被引文献11

  • 1Dennis LK. Analysis of the melanoma epidemic, both apparent and real: date from the 1973 through 1994 surveillance,epidemiology, and end results program registry[J]. Arch Dermatol , 1999,135 (3) :275-280.
  • 2Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation[J]. N Engl J Med, 1999 ,340( 17) : 1341-1348.
  • 3Singh AD, Tubbs R, Biscotti C, Schoenfield L, Trizzoi P. Chromasomal 3 and 8 status within hepatic metastasis of uveal melanoma[J]. Arch Patlwl Lab Med,2009 ,133(8) :1223-1227.
  • 4Yu GP, Hu DN, McCormick SA. Latitude and incidence of ocular melanoma[J]. Photochem. Photobiol,2006 ,82( 6) : 1621-1626.
  • 5Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy[J]. Nature,2007 ,445(7130) :851-857.
  • 6Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K, et al. 11-23 promotes tumour incidence and growth[J]. Nature, 2006,42(7101):461-465.
  • 7Ljqjic B, Radosavljevic G , Jovanovic I, Pavlovic S, Zdravkovic N, Milovanovic M, et al. Elevated serum level of 11-23 correlates with expression of VEGF in human colorectal carcinoma[J] . Arch Med Res ,2010 ,41 (3) :182-189.
  • 8Kato T , Furumoto H, Ogura T , Onishi Y, Irahara M, Yamano S, et al. Expression of 11-17 mRNA in Ovarian Cancer[J] . Biochem Biophys Res Commun,2001 ,282(3) :735-738.
  • 9Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway[J].J Exp Med,2009,206(7) :1457-1464.
  • 10Liu J, Duan Y, Cheng X, Liu J, Duan Y, Cheng X, et al. 11-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma[J]. Biochem. Biophys Res Commun, 2011,407 (2) : 348- 354.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部